Çöteli Cem, Canpolat Uğur, Kaya Ergün Barış, Şahiner Mehmet Levent, Aytemir Kudret
Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Turk Kardiyol Dern Ars. 2018 Jun;46(4):306-308. doi: 10.5543/tkda.2018.44884.
Percutaneous left atrial appendage (LAA) occlusion is an alternative therapeutic option for stroke prevention in patients with atrial fibrillation and contraindications for oral anticoagulation. There are few data available regarding the technical success of percutaneous LAA closure in patients with the previous implantation of an atrial septal defect (ASD) or a patent foramen ovale closure device. This is the description of a case of a successful LAA closure performed with an Amplatzer Amulet occluder device (St. Jude Medical, Inc., St. Paul, MN, USA) in a patient with a previous history of percutaneous ASD.
经皮左心耳(LAA)封堵术是房颤患者预防卒中的一种替代治疗选择,这些患者存在口服抗凝治疗的禁忌证。关于既往植入房间隔缺损(ASD)或卵圆孔未闭封堵装置的患者行LAA经皮封堵术的技术成功率,目前可用数据较少。本文描述了1例使用美国圣犹达医疗公司(位于明尼苏达州圣保罗)生产的Amplatzer Amulet封堵器成功封堵LAA的病例,该患者既往有ASD经皮介入治疗史。